Practice
Featured experience
ExxonMobil $59.5 billion acquisition of Pioneer Natural Resources
We are advising ExxonMobil on the transaction
PSG VI $6 billion fundraise and $2 billion continuation fund
We advised PSG on the fundraise for PSG VI and a multi-asset GP-led secondary continuation fund transaction
Circle $1.05 billion IPO
We are advising Circle on its IPO, the first IPO by a stablecoin issuer
Switch data center project financing transactions
We advised the lenders on the project financings
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026
Beacon Therapeutics $75 million Series C financing round
We advised Forbion on its participation in the financing round
J.P. Morgan arranges landmark U.S. commercial paper issuance on Solana
We advised J.P. Morgan on structuring the issuance of U.S. commercial paper on a major blockchain
J.P. Morgan arranges landmark U.S. commercial paper issuance on Solana
We advised J.P. Morgan on structuring the issuance of U.S. commercial paper on a major blockchain
J.P. Morgan arranges landmark U.S. commercial paper issuance on Solana
We advised J.P. Morgan on structuring the issuance of U.S. commercial paper on a major blockchain
26North investment in Bruin Capital’s $1 billion fundraise
We advised 26North on the investment
26North investment in Bruin Capital’s $1 billion fundraise
We advised 26North on the investment
26North investment in Bruin Capital’s $1 billion fundraise
We advised 26North on the investment